Transition Management in Post-Trial and Expanded Access Programs: Navigating Change with Precision
In the world of pharmaceutical development, Expanded Access Programs (EAPs) and Post-Trial Access (PTA) initiatives play a crucial role in delivering life-saving therapies to patients in need. These programs are essential for providing access to [...]